Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
Dana-Farber Cancer Institute
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Stanford University